Alumis (ALMS) EBT (2023 - 2026)
Alumis' (ALMS) quarterly EBT came in at -$144.0 million in Q2 2026, down 383.64% year-over-year from $50.8 million in Q2 2025, and down 54.93% quarter-over-quarter from -$92.9 million in Q4 2025.
Analysis
Alumis (ALMS) EBT (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported EBT for 4 consecutive years, with -$144.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT fell 383.64% year-over-year to -$144.0 million in Q2 2026; TTM through Jun 2026 was -$296.9 million, a 24.41% decrease from a year earlier, with the FY2025 full-year figure at -$251.9 million, up 14.39% from the prior year.
- EBT was -$144.0 million for Q2 2026 at Alumis, down from -$92.9 million in the prior quarter.
- Over five years, EBT peaked at $50.8 million in Q2 2025 and troughed at -$144.0 million in Q2 2026.
- A 4-year average of -$67.6 million and a median of -$74.7 million in 2024 frame the typical range for EBT.
- Across the five-year window, EBT soared 189.83% in 2025 and sank 383.64% in 2026, its largest moves.
- Over 4 years, EBT stood at -$40.1 million in 2023, then plunged by 136.12% to -$94.8 million in 2024, then increased by 1.93% to -$92.9 million in 2025, then slumped by 54.93% to -$144.0 million in 2026.
- The last three EBT figures came in at -$144.0 million (Q2 2026), -$92.9 million (Q4 2025), and -$110.8 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 2.77 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -10.25 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 1.39 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 1.53 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 542.00 Mn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -767.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 177.81 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 132.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -294.56 Mn |
| 10 | Alumis | 1.27 Bn | 765.76 Mn | - | -143.98 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -143.98 Mn |
| Dec 31, 2025 | -92.93 Mn |
| Sep 30, 2025 | -110.75 Mn |
| Jun 30, 2025 | 50.76 Mn |
| Mar 31, 2025 | -101.53 Mn |
| Dec 31, 2024 | -94.76 Mn |
| Sep 30, 2024 | -93.12 Mn |
| Jun 30, 2024 | -56.51 Mn |
| Mar 31, 2024 | -47.59 Mn |
| Dec 31, 2023 | -40.13 Mn |
| Sep 30, 2023 | -43.76 Mn |
| Jun 30, 2023 | -36.71 Mn |